Ars Pharmaceuticals Inc (SPRY) Profitability Comparisons, Net Margin, Gross Margin, Tax rate, Cash Flow Margin Comparisons - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Ars Pharmaceuticals Inc   (NASDAQ: SPRY)

Ars Pharmaceuticals Inc Profitability Comparisons

Select each Category to receive further Information



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

SPRY Profitability Ratio

 Company Industry Sector S&P 500
Gross Profit Margin (Q2 MRQ) 0 % 70.91 % 67.38 % 46.15 %
Gross Margin (Q2 TTM) 71.21 % 71.7 % 67.8 % 46.36 %
Gross Profit Margin 5 Yr. Avg. - 67.81 % 65.55 % 48.95 %
EBITDA Margin (Q2 MRQ) 3.02 % 21.48 % 18.44 % 20.46 %
EBITDA Margin (Q2 TTM) -129.1 % 25.18 % 20.78 % 20.1 %
EBITDA Margin 5 Yr. Avg. - 47.09 % 31.38 % 23.41 %
Operating Margin (Q2 MRQ) -182.62 % 17.3 % 16.52 % 16.05 %
Operating Margin (Q2 TTM) -184.96 % 20.35 % 17.83 % 16.34 %
Operating Margin 5 Yr. Avg. - 15.37 % 14.33 % 19.26 %
Pre-Tax Profit Margin (Q2 MRQ) 0 % 13.68 % 10.72 % 13.96 %
Pre-Tax Profit Margin (Q2 TTM) -131 % 16.7 % 12.68 % 13.09 %
Pre-Tax Profit Margin 5 Yr. Avg. - 12.98 % 10.37 % 13.52 %
Net Margin (Q2 MRQ) -185.21 % 10.12 % 8.02 % 11.42 %
Net Margin (Q2 TTM) -184.24 % 13.16 % 9.86 % 10.76 %
Net Margin 5 Yr. Avg. - 5.79 % 6.08 % 10.8 %



Business Segment Profit Margin
 
Revenue under supply agreements
  Explore Revenue under supply agreements Segment  -
Denmark
  Explore Denmark Segment  -
Product
  Explore Product Segment  -
US
  Explore US Segment  -
DK
  Explore DK Segment  -
Non Us
  Explore Non Us Segment  -